Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, have launched a new report which examines the research performance of each of the member countries of the G20 with a visual comparative snapshot for each nation. It also includes a special analysis of the G20 members’ COVID-19 research as indexed in the Web of Science™ research publication and citation index.
The report, The Annual G20 Scorecard – Research Performance 2021, has been created by the Institute for Scientific Information™ at Clarivate ahead of this year’s G20 Summit, which will be hosted virtually by Rome, Italy on October 30-31. It includes both a written summary and an array of graphs and exhibits that highlight the research performance of Argentina, Australia, Brazil, Canada, Mainland China, France, Germany, India, Indonesia, Italy, Japan, Mexico, Russia, Saudi Arabia, South Africa, South Korea, Turkey, the United Kingdom and the United States.
The report focuses on the different national responses to COVID-19 and the link to each region’s research investment and subject diversity. It finds that regions with more even research bases, especially the United States, Germany and the United Kingdom, tend to support a response across a wider range of COVID-19 topics. Other G20 nations with even less research bases tend toward a more specialized response. However, one notable exception is Brazil, where a less diverse research base has responded strongly to COVID-19, reflecting the relevant strengths in its research portfolio, particularly around biosciences.
Click here to read the original press release.
